Search Results

You are looking at 1 - 5 of 5 items for :

  • genetic alterations x
  • Advances and Future Directions in Pheochromocytoma and Paraganglioma x
  • Refine by access: Content accessible to me x
Clear All
Anne-Paule Gimenez-Roqueplo Université Paris Cité, PARCC, INSERM, Paris, France
Département de Médecine Génomique des Tumeurs et des Cancers, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France

Search for other papers by Anne-Paule Gimenez-Roqueplo in
Google Scholar
PubMed
Close
,
Mercedes Robledo Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain

Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Close
, and
Patricia L M Dahia Division of Hematology and Medical Oncology, Department Medicine, University of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio, Texas, USA
Mays Cancer Center at UTHSCSA, San Antonio, Texas, USA

Search for other papers by Patricia L M Dahia in
Google Scholar
PubMed
Close

Hypertension clearly stated that genetic studies should be considered for any patient diagnosed with PGL because these tumors carry the highest known heritability rate of any human neoplasm and because genetic alterations currently explain almost 80% of all

Open access
Karel Pacak Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Karel Pacak in
Google Scholar
PubMed
Close
and
Roderick Clifton-Bligh Department of Endocrinology Royal North Shore Hospital, University of Sydney, Australia

Search for other papers by Roderick Clifton-Bligh in
Google Scholar
PubMed
Close

speakers included Dr Robledo (’Pheochromocytoma and paraganglioma: dialogue between genetic and epigenetics’), Dr Eisenhofer (’Catecholamine system biology and biochemical diagnosis of pheochromocytoma and paraganglioma’) and Dr Taieb (’Nuclear medicine in

Free access
Susan Richter Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse, Dresden, Germany

Search for other papers by Susan Richter in
Google Scholar
PubMed
Close
,
Timothy J Garrett Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA

Search for other papers by Timothy J Garrett in
Google Scholar
PubMed
Close
,
Nicole Bechmann Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse, Dresden, Germany

Search for other papers by Nicole Bechmann in
Google Scholar
PubMed
Close
,
Roderick J Clifton-Bligh Cancer Genetics Laboratory, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, St Leonards, Australia
Department of Endocrinology, Royal North Shore Hospital, St Leonards, Australia

Search for other papers by Roderick J Clifton-Bligh in
Google Scholar
PubMed
Close
, and
Hans K Ghayee Department of Internal Medicine, Division of Endocrinology, University of Florida College of Medicine and Malcom Randall VA Medical Center, Gainesville, Florida, USA

Search for other papers by Hans K Ghayee in
Google Scholar
PubMed
Close

products and hence aids in the classification process. Genetic alterations have amongst others also metabolic consequences in a cell ( Fig. 2 ). Especially mutations affecting SDH, FH, or isocitrate dehydrogenase (IDH) lead to strong increases in

Open access
Paul Benjamin Loughrey Patrick G Johnston Centre for Cancer Research, Queen’s University, Belfast, UK
Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK

Search for other papers by Paul Benjamin Loughrey in
Google Scholar
PubMed
Close
,
Federico Roncaroli Geoffrey Jefferson Brain Research Centre, Division of Neuroscience and Experimental Psychology, School of Medicine, Manchester University, Manchester, UK

Search for other papers by Federico Roncaroli in
Google Scholar
PubMed
Close
,
Estelle Healy Department of Cellular Pathology, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK

Search for other papers by Estelle Healy in
Google Scholar
PubMed
Close
,
Philip Weir Department of Neurosurgery, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK

Search for other papers by Philip Weir in
Google Scholar
PubMed
Close
,
Madhu Basetti Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK

Search for other papers by Madhu Basetti in
Google Scholar
PubMed
Close
,
Ruth T Casey Department of Endocrinology, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK

Search for other papers by Ruth T Casey in
Google Scholar
PubMed
Close
,
Steven J Hunter Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK

Search for other papers by Steven J Hunter in
Google Scholar
PubMed
Close
, and
Márta Korbonits Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK

Search for other papers by Márta Korbonits in
Google Scholar
PubMed
Close

( Xekouki et al. 2012 ) and has since been known as the 3P (pituitary, paraganglioma, phaeochromocytoma) association (3PA) syndrome ( Xekouki et al. 2015 ). In some cases, no genetic alteration can be identified ( Denes et al. 2015 ). In addition to

Open access
Liang Zhang Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Liang Zhang in
Google Scholar
PubMed
Close
,
Tobias Åkerström Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Tobias Åkerström in
Google Scholar
PubMed
Close
,
Kazhan Mollazadegan Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Kazhan Mollazadegan in
Google Scholar
PubMed
Close
,
Felix Beuschlein Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich (USZ) and Univeristät Zürich (UZH), Zurich, Switzerland
Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany

Search for other papers by Felix Beuschlein in
Google Scholar
PubMed
Close
,
Karel Pacak Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Karel Pacak in
Google Scholar
PubMed
Close
,
Britt Skogseid Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Britt Skogseid in
Google Scholar
PubMed
Close
, and
Joakim Crona Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Joakim Crona in
Google Scholar
PubMed
Close

that metastatic PPGL lesions often present with a different behavior as compared to its primary tumor. Such differences in biology may indeed prove to be clinically relevant and could be translated into new therapeutic possibilities through genetic

Open access